NO992727D0 - Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen - Google Patents

Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen

Info

Publication number
NO992727D0
NO992727D0 NO992727A NO992727A NO992727D0 NO 992727 D0 NO992727 D0 NO 992727D0 NO 992727 A NO992727 A NO 992727A NO 992727 A NO992727 A NO 992727A NO 992727 D0 NO992727 D0 NO 992727D0
Authority
NO
Norway
Prior art keywords
pancreas
diagnostic agents
exocrine function
exocrine
function
Prior art date
Application number
NO992727A
Other languages
English (en)
Other versions
NO992727L (no
NO323757B1 (no
Inventor
Tadashi Kohno
Iasaburo Hosoi
Junko Ohshima
Kunihiko Shibata
Asuka Ito
Original Assignee
Tokyo Gas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Gas Co Ltd filed Critical Tokyo Gas Co Ltd
Publication of NO992727D0 publication Critical patent/NO992727D0/no
Publication of NO992727L publication Critical patent/NO992727L/no
Publication of NO323757B1 publication Critical patent/NO323757B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Atmospheric Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Obesity (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19992727A 1998-06-05 1999-06-04 Diagnostiske midler for pankreasksokrin funksjon i en pustetest, samt 13C- eller 14C-merket forbindelse eller salt. NO323757B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15785598 1998-06-05
JP14949699A JP3340699B2 (ja) 1998-06-05 1999-05-28 膵外分泌機能診断剤

Publications (3)

Publication Number Publication Date
NO992727D0 true NO992727D0 (no) 1999-06-04
NO992727L NO992727L (no) 1999-12-06
NO323757B1 NO323757B1 (no) 2007-07-02

Family

ID=26479372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992727A NO323757B1 (no) 1998-06-05 1999-06-04 Diagnostiske midler for pankreasksokrin funksjon i en pustetest, samt 13C- eller 14C-merket forbindelse eller salt.

Country Status (10)

Country Link
EP (1) EP0966975B1 (no)
JP (1) JP3340699B2 (no)
AU (1) AU729896B2 (no)
CA (1) CA2273549C (no)
DE (1) DE69927089T2 (no)
DK (1) DK0966975T3 (no)
ES (1) ES2249873T3 (no)
NO (1) NO323757B1 (no)
NZ (1) NZ336116A (no)
PT (1) PT966975E (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284219B1 (en) 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤
US7232559B1 (en) * 1999-06-04 2007-06-19 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
EP1316320A4 (en) * 2000-09-07 2005-12-07 Tokyo Gas Co Ltd PREPARATIONS FOR DIAGNOSING THE EXTRAPANCREATIC SECRETION FUNCTION
MXPA04001260A (es) * 2001-08-10 2004-05-27 Tokio Gas Company Ltd Agente de diagnostico para funcion exocrina pancreatica.
US7781396B2 (en) 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
DE60336546D1 (de) 2002-02-21 2011-05-12 Tokyo Gas Co Ltd Testagentien zur beurteilung der pharmakologischen wirkung eines arzneistoffs sowie verfahren und reagentien zum screening eines arzneistoffs mit ausgezeichneter verabreichungswirkung und/oder geringer nebenwirkung aus enzyme, enzyminhibitoren oder rezeptorliganden umfassenden arzneistoffen und/oder prodrugs davon
KR20040096618A (ko) * 2002-02-27 2004-11-16 캠브리지 이소토페 래버러토리즈사 폐기능 측정을 위한 13ｃ 표지된 물질의 용도
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
WO2004060791A1 (en) 2003-01-07 2004-07-22 Ramot At Tel Aviv University Ltd. Peptide nanostructures encapsulating a foreign material and method of manufacturing same
AU2004251522C1 (en) 2003-06-30 2011-12-15 Tel Aviv University Future Technology Development L.P. Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
EP1663199B1 (en) 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
US8568637B2 (en) 2004-08-02 2013-10-29 Ramot At Tel-Aviv University Ltd. Method of forming a fiber made of peptide nanostructures
US7732479B2 (en) 2004-08-19 2010-06-08 Tel Aviv University Future Technology Development L.P. Compositions for treating amyloid associated diseases
WO2006027780A2 (en) 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US7704955B2 (en) 2004-11-24 2010-04-27 Neopro Pain, Inc. Methods and compositions for modulating conditions in both mammals and plants
WO2007043048A2 (en) 2005-10-11 2007-04-19 Ramot At Tel Aviv University Ltd. Self-assembled fmoc-ff hydrogels
US7879212B2 (en) 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
CA2647835A1 (en) 2006-03-28 2007-10-04 Neopro Labs, Llc Methods and compositions for treating conditions
CA2683288A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
EP4308170A1 (en) 2021-03-18 2024-01-24 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279886A (en) * 1979-01-02 1981-07-21 University Patents, Inc. Test for pancreatic exocrine function
US4676974A (en) * 1984-05-17 1987-06-30 The Regents Of The University Of California Breath test for pancreatic exocrine function
EP0968001B1 (en) * 1997-02-03 2003-11-05 Mallinckrodt Inc. Method for the detection and localization of malignant human pancreatic tumours
US6284219B1 (en) * 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
NZ337946A (en) * 1998-09-25 2001-11-30 Tokyo Gas Co Ltd C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤

Also Published As

Publication number Publication date
EP0966975B1 (en) 2005-09-07
CA2273549A1 (en) 1999-12-05
JP2000053697A (ja) 2000-02-22
EP0966975A2 (en) 1999-12-29
AU729896B2 (en) 2001-02-15
DE69927089T2 (de) 2006-05-18
AU3316899A (en) 1999-12-16
NO992727L (no) 1999-12-06
JP3340699B2 (ja) 2002-11-05
NZ336116A (en) 2000-10-27
DE69927089D1 (de) 2005-10-13
PT966975E (pt) 2005-11-30
CA2273549C (en) 2006-10-24
ES2249873T3 (es) 2006-04-01
DK0966975T3 (da) 2005-10-03
EP0966975A3 (en) 2002-04-17
NO323757B1 (no) 2007-07-02

Similar Documents

Publication Publication Date Title
NO992727L (no) Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen
DE69838231D1 (de) Kanülenanordnung
FR2770110B1 (fr) Boitier, du type boitier de maquillage
NO994062L (no) Stralingsdetektor-sammenstilling
PT989130E (pt) Trifluorometilalquilmino-triazolopirimidinas fingicidas opticamente activas
DE69907371D1 (de) Verriegelungsanordnung
TR199901877A3 (tr) Zararli eklem bacaklilarin imhasi için terkip.
NO20000857L (no) Blandeapparat
BR9901100B1 (pt) composiÇço fungicida lÍquida e concentrada.
ID25510A (id) Komposisi anti keringat atau deodoran
DE69908446D1 (de) Programmfehlerbeseitigung
DE69935145D1 (de) Steckverbinderanordnung
DE19983670T1 (de) Vibratoranordnung
DE69916207D1 (de) Tintenstrahlaufzeichnungselement
NO20003849D0 (no) Borehulls-motormontasje
ATE286131T1 (de) Attenuierte pestiviren
DE69900351D1 (de) Prüfkopfanordnung
NO20005507D0 (no) Spylerenseapparat
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
FI19992527A (fi) Sahakokoonpano
NO307859B1 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
NO20022367L (no) Låssammenstilling
FI971594A0 (fi) Liitosjärjestely
TR199900594A3 (tr) Bulasik makinasi.
IT1302693B1 (it) Procedimento per il risanamento degli argini

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees